136 related articles for article (PubMed ID: 14700725)
1. Posterior cingulate metabolic changes occur in Parkinson's disease patients without dementia.
Camicioli RM; Korzan JR; Foster SL; Fisher NJ; Emery DJ; Bastos AC; Hanstock CC
Neurosci Lett; 2004 Jan; 354(3):177-80. PubMed ID: 14700725
[TBL] [Abstract][Full Text] [Related]
2. Metabolite ratios in the posterior cingulate cortex do not track cognitive decline in Parkinson's disease in a clinical setting.
Almuqbel M; Melzer TR; Myall DJ; MacAskill MR; Pitcher TL; Livingston L; Wood KL; Keenan RJ; Dalrymple-Alford JC; Anderson TJ
Parkinsonism Relat Disord; 2016 Jan; 22():54-61. PubMed ID: 26627939
[TBL] [Abstract][Full Text] [Related]
3. Brain metabolism differs in Alzheimer's disease and Parkinson's disease dementia.
Griffith HR; den Hollander JA; Okonkwo OC; O'Brien T; Watts RL; Marson DC
Alzheimers Dement; 2008 Nov; 4(6):421-7. PubMed ID: 19012867
[TBL] [Abstract][Full Text] [Related]
4. Using proton magnetic resonance spectroscopy to identify mild cognitive impairment.
Wang T; Xiao S; Li X; Ding B; Ling H; Chen K; Fang Y
Int Psychogeriatr; 2012 Jan; 24(1):19-27. PubMed ID: 21676281
[TBL] [Abstract][Full Text] [Related]
5. (1)H-MRS asymmetry changes in the anterior and posterior cingulate gyrus in patients with mild cognitive impairment and mild Alzheimer's disease.
Guo Z; Liu X; Hou H; Wei F; Chen X; Shen Y; Chen W
Compr Psychiatry; 2016 Aug; 69():179-85. PubMed ID: 27423359
[TBL] [Abstract][Full Text] [Related]
6. Regional metabolic changes in the hippocampus and posterior cingulate area detected with 3-Tesla magnetic resonance spectroscopy in patients with mild cognitive impairment and Alzheimer disease.
Wang Z; Zhao C; Yu L; Zhou W; Li K
Acta Radiol; 2009 Apr; 50(3):312-9. PubMed ID: 19235582
[TBL] [Abstract][Full Text] [Related]
7. Association of 1H-MR spectroscopy and cerebrospinal fluid biomarkers in Alzheimer's disease: diverging behavior at three different brain regions.
Bittner DM; Heinze HJ; Kaufmann J
J Alzheimers Dis; 2013; 36(1):155-63. PubMed ID: 23579327
[TBL] [Abstract][Full Text] [Related]
8. In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease.
Frederick BD; Lyoo IK; Satlin A; Ahn KH; Kim MJ; Yurgelun-Todd DA; Cohen BM; Renshaw PF
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1313-22. PubMed ID: 15588758
[TBL] [Abstract][Full Text] [Related]
9. Decreased N-Acetyl Aspartate/Myo-Inositol Ratio in the Posterior Cingulate Cortex Shown by Magnetic Resonance Spectroscopy May Be One of the Risk Markers of Preclinical Alzheimer's Disease: A 7-Year Follow-Up Study.
Waragai M; Moriya M; Nojo T
J Alzheimers Dis; 2017; 60(4):1411-1427. PubMed ID: 28968236
[TBL] [Abstract][Full Text] [Related]
10. Anterior cingulate integrity: executive and neuropsychiatric features in Parkinson's disease.
Lewis SJ; Shine JM; Duffy S; Halliday G; Naismith SL
Mov Disord; 2012 Sep; 27(10):1262-7. PubMed ID: 22865474
[TBL] [Abstract][Full Text] [Related]
11. Early Alzheimer's disease neuropathology detected by proton MR spectroscopy.
Murray ME; Przybelski SA; Lesnick TG; Liesinger AM; Spychalla A; Zhang B; Gunter JL; Parisi JE; Boeve BF; Knopman DS; Petersen RC; Jack CR; Dickson DW; Kantarci K
J Neurosci; 2014 Dec; 34(49):16247-55. PubMed ID: 25471565
[TBL] [Abstract][Full Text] [Related]
12. Metabolite investigation in both anterior and posterior cingulate gyri in Alzheimer's disease spectrum using 3-tesla MR spectroscopy.
Lim TS; Hong YH; Lee HY; Choi JY; Kim HS; Moon SY
Dement Geriatr Cogn Disord; 2012; 33(2-3):149-55. PubMed ID: 22722669
[TBL] [Abstract][Full Text] [Related]
13. Functional investigation of bilateral posterior cingulate gyri using multivoxel MR spectroscopy.
Lim TS; Hong YH; Choi JY; Kim HS; Moon SY
Eur Neurol; 2012; 67(5):279-86. PubMed ID: 22472573
[TBL] [Abstract][Full Text] [Related]
14. Whole-brain proton MR spectroscopic imaging in Parkinson's disease.
Levin BE; Katzen HL; Maudsley A; Post J; Myerson C; Govind V; Nahab F; Scanlon B; Mittel A
J Neuroimaging; 2014; 24(1):39-44. PubMed ID: 23228009
[TBL] [Abstract][Full Text] [Related]
15. Marked N-acetylaspartate and choline metabolite changes in Parkinson's disease patients with mild cognitive impairment.
Nie K; Zhang Y; Huang B; Wang L; Zhao J; Huang Z; Gan R; Wang L
Parkinsonism Relat Disord; 2013 Mar; 19(3):329-34. PubMed ID: 23238068
[TBL] [Abstract][Full Text] [Related]
16. Hippocampal metabolic abnormalities in mild cognitive impairment and Alzheimer's disease.
Ackl N; Ising M; Schreiber YA; Atiya M; Sonntag A; Auer DP
Neurosci Lett; 2005 Aug 12-19; 384(1-2):23-8. PubMed ID: 15905028
[TBL] [Abstract][Full Text] [Related]
17. [Hydrogen proton MR spectroscopy of posterior portion cingulate gyrus of patients with Alzheimer's disease: a case control study].
Wang T; Xiao SF; Li X; Wang Y; Ding B; Ling HW; Chen KM
Zhonghua Yi Xue Za Zhi; 2009 Jan; 89(1):37-40. PubMed ID: 19489242
[TBL] [Abstract][Full Text] [Related]
18. A decrease in N-acetylaspartate and an increase in myoinositol in the anterior cingulate gyrus are associated with behavioral and psychological symptoms in Alzheimer's disease.
Shinno H; Inagaki T; Miyaoka T; Okazaki S; Kawamukai T; Utani E; Inami Y; Horiguchi J
J Neurol Sci; 2007 Sep; 260(1-2):132-8. PubMed ID: 17540407
[TBL] [Abstract][Full Text] [Related]
19. 3.0 T MRI arterial spin labeling and magnetic resonance spectroscopy technology in the application of Alzheimer's disease.
Zou JX; Wang MJ; Lei XJ; Chen XG
Exp Gerontol; 2014 Dec; 60():31-6. PubMed ID: 25220149
[TBL] [Abstract][Full Text] [Related]
20. Brain glutamate levels are decreased in Alzheimer's disease: a magnetic resonance spectroscopy study.
Fayed N; Modrego PJ; Rojas-Salinas G; Aguilar K
Am J Alzheimers Dis Other Demen; 2011 Sep; 26(6):450-6. PubMed ID: 21921084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]